These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32888253)

  • 1. Proteomics identifies EGF-like domain multiple 7 as a potential therapeutic target for epidermal growth factor receptor-positive glioma.
    Wang FY; Wang-Gou SY; Cao H; Jiang N; Yang Q; Huang Q; Huang CH; Li XJ
    Cancer Commun (Lond); 2020 Oct; 40(10):518-530. PubMed ID: 32888253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel role for epidermal growth factor-like domain 7 in metastasis of human hepatocellular carcinoma.
    Wu F; Yang LY; Li YF; Ou DP; Chen DP; Fan C
    Hepatology; 2009 Dec; 50(6):1839-50. PubMed ID: 19824075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VE-statin/Egfl7 expression in malignant glioma and its relevant molecular network.
    Huang C; Yuan X; Wan Y; Liu F; Chen X; Zhan X; Li X
    Int J Clin Exp Pathol; 2014; 7(3):1022-31. PubMed ID: 24696719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of EGFL7/EGFR-signaling pathway in migration and invasion of growth hormone-producing pituitary adenomas.
    Liu Q; Zhang J; Gao H; Yuan T; Kang J; Jin L; Gui S; Zhang Y
    Sci China Life Sci; 2018 Aug; 61(8):893-901. PubMed ID: 29951953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGFL7 drives the evolution of resistance to EGFR inhibitors in lung cancer by activating NOTCH signaling.
    Wang Y; Chen P; Zhao M; Cao H; Zhao Y; Ji M; Hou P; Chen M
    Cell Death Dis; 2022 Oct; 13(10):910. PubMed ID: 36309484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGFL7 is an intercellular EGFR signal messenger that plays an oncogenic role in glioma.
    Wang FY; Kang CS; Wang-Gou SY; Huang CH; Feng CY; Li XJ
    Cancer Lett; 2017 Jan; 384():9-18. PubMed ID: 27725228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VE-statin/Egfl7 siRNA inhibits angiogenesis in malignant glioma in vitro.
    Huang C; Yuan X; Li Z; Tian Z; Zhan X; Zhang J; Li X
    Int J Clin Exp Pathol; 2014; 7(3):1077-84. PubMed ID: 24696724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGF repeats of epidermal growth factor‑like domain 7 promote endothelial cell activation and tumor escape from the immune system.
    Pinte S; Delfortrie S; Havet C; Villain G; Mattot V; Soncin F
    Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34738625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor receptor promotes glioma progression by regulating xCT and GluN2B-containing N-methyl-d-aspartate-sensitive glutamate receptor signaling.
    Suina K; Tsuchihashi K; Yamasaki J; Kamenori S; Shintani S; Hirata Y; Okazaki S; Sampetrean O; Baba E; Akashi K; Mitsuishi Y; Takahashi F; Takahashi K; Saya H; Nagano O
    Cancer Sci; 2018 Dec; 109(12):3874-3882. PubMed ID: 30298963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The soluble form of the tumor suppressor Lrig1 potently inhibits in vivo glioma growth irrespective of EGF receptor status.
    Johansson M; Oudin A; Tiemann K; Bernard A; Golebiewska A; Keunen O; Fack F; Stieber D; Wang B; Hedman H; Niclou SP
    Neuro Oncol; 2013 Sep; 15(9):1200-11. PubMed ID: 23723255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology.
    Goldman CK; Kim J; Wong WL; King V; Brock T; Gillespie GY
    Mol Biol Cell; 1993 Jan; 4(1):121-33. PubMed ID: 7680247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor-dependent dissociation of CrkII proto-oncogene product from the epidermal growth factor receptor in human glioma cells.
    Katayama H; Hashimoto Y; Kiyokawa E; Nakaya M; Sakamoto A; Machinami R; Kurata T; Mochizuki N; Matsuda M
    Jpn J Cancer Res; 1999 Oct; 90(10):1096-103. PubMed ID: 10595738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro inhibitory effect of EGFL7-RNAi on endothelial angiogenesis in glioma.
    Li Q; Wang AY; Xu QG; Liu DY; Xu PX; Yu D
    Int J Clin Exp Pathol; 2015; 8(10):12234-42. PubMed ID: 26722408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA LPP-AS2 promotes glioma tumorigenesis via miR-7-5p/EGFR/PI3K/AKT/c-MYC feedback loop.
    Zhang X; Niu W; Mu M; Hu S; Niu C
    J Exp Clin Cancer Res; 2020 Sep; 39(1):196. PubMed ID: 32962742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor receptor and ligand family expression and activity in glioblastoma.
    von Achenbach C; Weller M; Szabo E
    J Neurochem; 2018 Oct; 147(1):99-109. PubMed ID: 29953622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting EGFL7 expression through RNA interference suppresses renal cell carcinoma growth by inhibiting angiogenesis.
    Xu HF; Chen L; Liu XD; Zhan YH; Zhang HH; Li Q; Wu B
    Asian Pac J Cancer Prev; 2014; 15(7):3045-50. PubMed ID: 24815445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and clinical significance of EGFL7 in malignant glioma.
    Huang CH; Li XJ; Zhou YZ; Luo Y; Li C; Yuan XR
    J Cancer Res Clin Oncol; 2010 Nov; 136(11):1737-43. PubMed ID: 20213100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGFL7: Master regulator of cancer pathogenesis, angiogenesis and an emerging mediator of bone homeostasis.
    Hong G; Kuek V; Shi J; Zhou L; Han X; He W; Tickner J; Qiu H; Wei Q; Xu J
    J Cell Physiol; 2018 Nov; 233(11):8526-8537. PubMed ID: 29923200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor and laminin receptors contribute to migratory and invasive properties of gliomas.
    Tysnes BB; Haugland HK; Bjerkvig R
    Invasion Metastasis; 1997; 17(5):270-80. PubMed ID: 9876221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of epidermal growth factor (EGF)/transforming growth factor-alpha by human lung cancer cells determines their response to EGF receptor tyrosine kinase inhibition in the lungs of mice.
    Wu W; O'Reilly MS; Langley RR; Tsan RZ; Baker CH; Bekele N; Tang XM; Onn A; Fidler IJ; Herbst RS
    Mol Cancer Ther; 2007 Oct; 6(10):2652-63. PubMed ID: 17913856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.